Recent actions by U.S. House lawmakers have cast a spotlight on GenScript, a Chinese Contract Development and Manufacturing Organization (CDMO), and its cell therapy division, Legend Biotech, amidst concerns of potential Chinese Communist Party (CCP) influence within the American biotech realm.
The Cell Banking Outsourcing Market is on the brink of a significant upswing, with projections estimating a surge from a robust USD 11.03 billion in 2022 to a staggering USD 33.12 billion by 2029. This exponential growth, driven by an impressive Compound Annual Growth Rate (CAGR) of 17.01%,
In a significant expansion of its life sciences portfolio, global science and technology leader Merck has announced a definitive agreement to purchase Mirus Bio for a staggering $600 million. Mirus Bio, a pioneering life sciences company, specializes in developing transfection reagents, a
Within the dynamic landscape of the Contract Development and Manufacturing Organization (CDMO) industry, strategic alliances are becoming increasingly crucial. The latest collaboration between Japan's AGC Biologics and the Netherlands-based BioConnection illustrates this point poignantly. They
The biotechnology sector could be on the brink of a substantial change as legislative gears turn with the possibility of the BIOSECURE Act being widened to encompass drug developers. This pivot towards inclusive scrutiny, primarily targeting relationships with Chinese biopharma entities, sparks a
The biopharmaceutical industry is on the cusp of a manufacturing evolution, largely due to advancements in analytical technologies. A key player that has emerged in this transformative period is Raman spectroscopy. Renowned for its rapid, nondestructive analysis capabilities, Raman spectroscopy is
